Overall, the findings of this study in conjunction with those of the studies by Lu et al. [2], Van Horssen et al. [10] and Sadeghian et al. [3] have indicated evidence of MRC dysfunction in EAE and MS, although this impairment in MRC function may not be confined to the CNS. The gene discussed is CD200; the disease is myeloid sarcoma.